Tushar Salukhe is an Honorary Senior Lecturer at the National Heart and Lung Institute, Imperial College. He is a Consultant Cardiologist specialising in cardiac electrophysiology and cardiac devices at the Royal Brompton and Harefield Hospitals.
Dr Salukhe specialises in the care and treatment of patients with cardiac arrhythmias, including advanced mapping and ablation and implantation of complex cardiac devices including defibrillators and biventricular pacemakers. His main clinical and academic focus is in the ablation of atrial arrhythmia, and in particular atrial fibrillation. His other specialist interest includes the care and treatment of patients with vasovagal syncope (fainting or transient loss of consciousness).
He read medicine at Imperial College, London where he obtained a first class degree in medical science in 1995 and subsequently qualified in first place in medicine with distinctions in 1998. After training in internal medicine and obtaining his MRCP, he won funding from the British Heart Foundation to pursue his doctorate in pacing therapies for heart failure at the National Heart and Lung Institute under the supervision and tutelage of Professors Richard Sutton and Phillip Poole-Wilson. He obtained his MD in 2008.
Research continued to be a fundamental aspect to his specialist training in cardiology and electrophysiology at prominent centres such as the Royal Brompton, Hammersmith, and St Mary’s Hospitals in London. His penultimate training year was spent at the renowned Universitätsklinikum Hamburg-Eppendorf in Germany on an advanced ablation fellowship. This fellowship was also funded by the British Heart Foundation based on a research programme designed and written by Dr Salukhe.
Dr Salukhe was appointed consultant cardiac electrophysiologist at the Royal Brompton and Harefield NHS Foundation Trust in October 2011.
et al., 2012, Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: an assessment of 1000 consecutive patients undergoing atrial fibrillation ablation, Europace, Vol:14, ISSN:1099-5129, Pages:325-330
et al., 2011, Narrow Complex Tachycardia with Alternating Cycle Length: What is the Mechanism?, Journal of Cardiovascular Electrophysiology, Vol:22, ISSN:1045-3873, Pages:1399-1401
et al., 2010, Persistence of pulmonary vein isolation after robotic remote-navigated ablation for atrial fibrillation and its relation to clinical outcome., J Cardiovasc Electrophysiol, Vol:21, Pages:1079-1084
et al., 2010, Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation, Heart, Vol:96, ISSN:1468-201X, Pages:1379-1384
et al., 2010, Atrial fibrillation cycle length is a sole independent predictor of a substrate for consecutive arrhythmias in patients with persistent atrial fibrillation., Circ Arrhythm Electrophysiol, Vol:3, Pages:351-360